Article
Correction of a urea cycle defect after ex vivo gene editing of human hepatocytes.
Molecular therapy : the journal of the American Society of Gene Therapy - 5 May 2021
Zabulica Mihaela, Srinivasan Raghuraman C, Akcakaya Pinar, Allegri Gabriella, Bestas Burcu, Firth Mike, Hammarstedt Christina, Jakobsson Tomas, Jakobsson Towe, Ellis Ewa, Jorns Carl, Makris Georgios, Scherer Tanja, Rimann Nicole, van Zuydam Natalie R, Gramignoli Roberto, Forslöw Anna, Engberg Susanna, Maresca Marcello, Rooyackers Olav, Thöny Beat, Häberle Johannes, Rosen Barry, Strom Stephen C
Abstract excerpt
Ornithine transcarbamylase deficiency (OTCD) is a monogenic disease of ammonia metabolism in hepatocytes. Severe disease is frequently treated by orthotopic liver transplantation. An attractive approach is the correction of a patient's own cells to regenerate the liver with gene-repaired hepatocytes. This study investigates the efficacy and safety of ex vivo correction of primary human hepatocytes. Hepatocytes...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
